These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33360004)

  • 21. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
    Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
    Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
    Ramzi S; Najeeb E; Coulthard J; Jenkins S
    Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
    Grimm LJ; Ryser MD; Partridge AH; Thompson AM; Thomas JS; Wesseling J; Hwang ES
    Ann Surg Oncol; 2017 Nov; 24(12):3534-3540. PubMed ID: 28795370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
    Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
    Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?
    Flanagan MR; Stempel M; Brogi E; Morrow M; Cody HS
    Ann Surg Oncol; 2019 Sep; 26(9):2738-2746. PubMed ID: 31147995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
    Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
    Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
    Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
    Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.
    Mannu GS; Groen EJ; Wang Z; Schaapveld M; Lips EH; Chung M; Joore I; van Leeuwen FE; Teertstra HJ; Winter-Warnars GAO; Darby SC; Wesseling J
    Breast Cancer Res Treat; 2019 Nov; 178(2):409-418. PubMed ID: 31388937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision.
    Walters LL; Pang JC; Zhao L; Jorns JM
    Histopathology; 2015 Mar; 66(4):577-86. PubMed ID: 25231210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
    Jakub JW; Murphy BL; Gonzalez AB; Conners AL; Henrichsen TL; Maimone S; Keeney MG; McLaughlin SA; Pockaj BA; Chen B; Musonza T; Harmsen WS; Boughey JC; Hieken TJ; Habermann EB; Shah HN; Degnim AC
    Ann Surg Oncol; 2017 Oct; 24(10):2915-2924. PubMed ID: 28766196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
    Mustafa RE; DeStefano LM; Bahng J; Yoon-Flannery K; Fisher CS; Zhang PJ; Tchou J; Czerniecki BJ; De La Cruz LM
    Ann Surg Oncol; 2017 Oct; 24(10):2999-3003. PubMed ID: 28766212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
    Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
    Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lesion Size on Ultrasonography Predicts Potential Invasion in Ductal Carcinoma in situ Preoperatively Diagnosed by Breast Needle Biopsy.
    Shimoyama K; Osako T; Mitsuhashi T; Akiyama F; Iwase T
    Acta Med Okayama; 2017 Jun; 71(3):233-240. PubMed ID: 28655943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
    Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    J Am Coll Radiol; 2018 Mar; 15(3 Pt B):527-534. PubMed ID: 29398498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ.
    Wu H; Jiang Y; Tian H; Ye X; Cui C; Shi S; Chen M; Ding Z; Li S; Huang Z; Luo Y; Peng Q; Xu J; Dong F
    Comput Methods Programs Biomed; 2024 Mar; 245():108039. PubMed ID: 38266556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.